查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1608127

胰岛素输送设备市场：按产品、最终用户划分 - 全球预测 2025-2030 年

Insulin Delivery Devices Market by Product (Insulin Injectors, Insulin Pens, Insulin Pumps), End-User (Homecare, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年胰岛素输送设备市值为285.5亿美元，预计到2024年将达到306.1亿美元，复合年增长率为8.00%，到2030年将达到489.3亿美元。

胰岛素输送设备市场包括多种用于注射胰岛素给糖尿病患者的产品。这些设备包括注射器、胰岛素笔、胰岛素帮浦和喷射注射器，每种设备都满足不同的患者需求和偏好。由于人口老化、生活方式的改变和肥胖率的增加，全球糖尿病盛行率不断上升，推动了对此类设备的需求。胰岛素输送设备用于管理第 1 型和第 2 型糖尿病，最终用户是个人、医疗保健提供者和医院。该市场的成长是由于人们对糖尿病管理的认识不断提高、提高患者便利性的设备设计技术进步以及对家庭医疗保健解决方案的日益关注而推动的。新的商机在于越来越多地采用将智慧胰岛素笔和胰岛素帮浦与连续血糖监测结合的闭合迴路系统。这些创新将显着改善血糖控制，并为市场相关人员创造重大商机。然而，高成本、有限的报销政策以及先进设备的安全问题等挑战正在阻碍市场扩张。此外，新设备核准方面的监管障碍也是一个障碍。儘管存在这些挑战，市场仍提供了巨大的创新潜力，特别是在人工智慧和机器学习的整合以进行胰岛素剂量的预测分析方面。扩大与数位健康平台的连接也可以开闢新的业务途径。研究的重点是提高设备的可用性和提高胰岛素输送系统的准确性。奈米递送技术和生物整合设备的进步有可能进一步改变患者的依从性和结果。由于市场参与企业必须透过以患者为中心的解决方案进行创新才能持续成长，竞争仍在继续。分析当地医疗保健政策、患者人口统计数据，并与医疗机构合作进行大规模试验，为获取和扩大市场占有率提供可操作的见解，确保全面了解并有效回应患者需求。

主要市场统计
基准年[2023] 285.5亿美元
预计年份 [2024] 306.1亿美元
预测年份 [2030] 489.3亿美元
复合年增长率（%） 8.00%

市场动态：揭示快速发展的胰岛素输送设备市场的关键市场洞察

供需的动态交互作用正在改变胰岛素输送设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 慢性病的增加及先进胰岛素输送设备的采用
    • 世界各地糖尿病和肥胖人口不断增加
    • 提高消费者对现代胰岛素输送设备的认识
  • 市场限制因素
    • 胰岛素输送设备高成本且缺乏保险
  • 市场机会
    • 胰岛素输送装置的技术进步
    • 自动胰岛素输送装置简介
  • 市场挑战
    • 严格的政府法规和复杂的产品核可流程

波特五力：驾驭胰岛素输送设备市场的策略工具

波特的五力框架是了解胰岛素输送设备市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解胰岛素输送设备市场的外部影响

外部宏观环境因素在塑造胰岛素输送设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解胰岛素输送设备市场的竞争格局

胰岛素输送设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵胰岛素输送设备市场供应商的绩效评估

FPNV定位矩阵是评估胰岛素输送设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了胰岛素输送设备市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，胰岛素输送设备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的增加及先进胰岛素管理设备的引进
      • 糖尿病和肥胖症在世界范围内呈上升趋势
      • 消费者对现代胰岛素输送设备的认识不断增强
    • 抑制因素
      • 胰岛素输送装置成本高且保险范围有限
    • 机会
      • 胰岛素输送装置的技术进步
      • 自动胰岛素输送装置简介
    • 任务
      • 更严格的政府法规和更复杂的产品核可流程
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章胰岛素输送设备市场：副产品

  • 胰岛素注射器
  • 胰岛素笔
  • 胰岛素帮浦
  • 胰岛素注射器

第七章胰岛素输送设备市场：依最终用户分类

  • 居家护理
  • 医院

第 8 章美洲胰岛素输送设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太胰岛素输送设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲的胰岛素输送设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Baxter International Inc
  • Becton, Dickinson and Company
  • Biocon Ltd.
  • Braun Melsungen AG
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company, Ltd.
  • Dr Reddy's Laboratories Ltd
  • Eli Lilly and Company
  • F. Hoffmann-La Roche, Ltd.
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Sanofi SA
  • Tandem Diabetes Care, Inc.
  • TOPAS Advanced Polymers GmbH
  • Ypsomed AG
  • Zealand Pharma A/S
Product Code: MRR-ED54C46E8A4A

The Insulin Delivery Devices Market was valued at USD 28.55 billion in 2023, expected to reach USD 30.61 billion in 2024, and is projected to grow at a CAGR of 8.00%, to USD 48.93 billion by 2030.

The insulin delivery devices market encompasses a wide range of products designed to administer insulin to individuals with diabetes. These devices include syringes, insulin pens, insulin pumps, and jet injectors, each catering to different patient needs and preferences. The necessity for such devices stems from the global rise in diabetes prevalence, compounded by aging populations, lifestyle changes, and increasing obesity rates. Insulin delivery devices are employed in both Type 1 and Type 2 diabetes management, with end-users comprising individuals, healthcare providers, and hospitals. Growth in this market is driven by heightened awareness of diabetes management, technological advancements in device design enhancing patient convenience, and a stronger focus on home healthcare solutions. Emerging opportunities lie in the increasing adoption of smart insulin pens and closed-loop systems that integrate continuous glucose monitoring with insulin pumps. These innovations can significantly enhance glycemic control, presenting substantial opportunities for market players. However, challenges such as high costs, limited reimbursement policies, and safety concerns of advanced devices hamper market expansion. Additionally, regulatory hurdles for new device approvals pose barriers. Despite these challenges, the market offers significant potential for innovation, particularly in the integration of artificial intelligence and machine learning for predictive analytics in insulin administration. Expanding device connectivity with digital health platforms can also offer new business avenues. Research can focus on enhancing the user-friendliness of devices and improving the precision of insulin delivery systems. Advancements in nano-delivery technologies and biologically integrated devices may further revolutionize patient adherence and outcomes. The market remains competitive, with participants needing to align innovations with patient-centric solutions to continue fostering growth. Analyzing regional healthcare policies, patient demographics, and collaborating with healthcare facilities for large-scale trials can provide actionable insights into capturing and expanding market shares, ensuring a comprehensive understanding and addressing patient needs effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 28.55 billion
Estimated Year [2024] USD 30.61 billion
Forecast Year [2030] USD 48.93 billion
CAGR (%) 8.00%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insulin Delivery Devices Market

The Insulin Delivery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing chronic diseases and adoption of advanced devices for insulin delivery
    • Increasing diabetic & obese population across the globe
    • Rising consumer awareness about the latest insulin delivery devices
  • Market Restraints
    • High cost of insulin delivery devices and lack of insurance coverage
  • Market Opportunities
    • Technological advancements in insulin delivery devices
    • Introduction of automated insulin delivery devices
  • Market Challenges
    • Increasing stringent government rules and complicated product approval process

Porter's Five Forces: A Strategic Tool for Navigating the Insulin Delivery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insulin Delivery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insulin Delivery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insulin Delivery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insulin Delivery Devices Market

A detailed market share analysis in the Insulin Delivery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insulin Delivery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insulin Delivery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insulin Delivery Devices Market

A strategic analysis of the Insulin Delivery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insulin Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Baxter International Inc, Becton, Dickinson and Company, Biocon Ltd., Braun Melsungen AG, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Ltd., Dr Reddy's Laboratories Ltd, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Insulet Corporation, Johnson & Johnson, Medtronic PLC, Merck & Co., Inc., Novo Nordisk A/S, Sanofi SA, Tandem Diabetes Care, Inc., TOPAS Advanced Polymers GmbH, Ypsomed AG, and Zealand Pharma A/S.

Market Segmentation & Coverage

This research report categorizes the Insulin Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Insulin Injectors, Insulin Pens, Insulin Pumps, and Insulin Syringes.
  • Based on End-User, market is studied across Homecare and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing chronic diseases and adoption of advanced devices for insulin delivery
      • 5.1.1.2. Increasing diabetic & obese population across the globe
      • 5.1.1.3. Rising consumer awareness about the latest insulin delivery devices
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of insulin delivery devices and lack of insurance coverage
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in insulin delivery devices
      • 5.1.3.2. Introduction of automated insulin delivery devices
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing stringent government rules and complicated product approval process
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Insulin Delivery Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Insulin Injectors
  • 6.3. Insulin Pens
  • 6.4. Insulin Pumps
  • 6.5. Insulin Syringes

7. Insulin Delivery Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Homecare
  • 7.3. Hospitals

8. Americas Insulin Delivery Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Insulin Delivery Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Insulin Delivery Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Baxter International Inc
  • 3. Becton, Dickinson and Company
  • 4. Biocon Ltd.
  • 5. Braun Melsungen AG
  • 6. Bristol-Myers Squibb Company
  • 7. Daiichi Sankyo Company, Ltd.
  • 8. Dr Reddy's Laboratories Ltd
  • 9. Eli Lilly and Company
  • 10. F. Hoffmann-La Roche, Ltd.
  • 11. Insulet Corporation
  • 12. Johnson & Johnson
  • 13. Medtronic PLC
  • 14. Merck & Co., Inc.
  • 15. Novo Nordisk A/S
  • 16. Sanofi SA
  • 17. Tandem Diabetes Care, Inc.
  • 18. TOPAS Advanced Polymers GmbH
  • 19. Ypsomed AG
  • 20. Zealand Pharma A/S

LIST OF FIGURES

  • FIGURE 1. INSULIN DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. INSULIN DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INSULIN DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INSULIN DELIVERY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023